118 related articles for article (PubMed ID: 18778441)
21. Dynorphin and prodynorphin mRNA changes in the striatum during nicotine withdrawal.
Isola R; Zhang H; Tejwani GA; Neff NH; Hadjiconstantinou M
Synapse; 2008 Jun; 62(6):448-55. PubMed ID: 18361441
[TBL] [Abstract][Full Text] [Related]
22. Chronic intraperitoneal injection of interferon-alpha reduces serotonin levels in various regions of rat brain, but does not change levels of serotonin transporter mRNA, nitrite or nitrate.
Sato T; Suzuki E; Yokoyama M; Semba J; Watanabe S; Miyaoka H
Psychiatry Clin Neurosci; 2006 Aug; 60(4):499-506. PubMed ID: 16884454
[TBL] [Abstract][Full Text] [Related]
23. Preexposure to nicotine alters the subsequent locomotor stimulant effects of bupropion in rats.
Wilkinson JL; Palmatier MI; Bevins RA
Nicotine Tob Res; 2006 Feb; 8(1):141-6. PubMed ID: 16497608
[TBL] [Abstract][Full Text] [Related]
24. Serotonin mediates beneficial effects of Hypericum perforatum on nicotine withdrawal signs.
Mannucci C; Pieratti A; Firenzuoli F; Caputi AP; Calapai G
Phytomedicine; 2007 Oct; 14(10):645-51. PubMed ID: 17689233
[TBL] [Abstract][Full Text] [Related]
25. Involvement of neuropeptide Y Y(1) receptors in the acute, chronic and withdrawal effects of nicotine on feeding and body weight in rats.
Nakhate KT; Dandekar MP; Kokare DM; Subhedar NK
Eur J Pharmacol; 2009 May; 609(1-3):78-87. PubMed ID: 19285064
[TBL] [Abstract][Full Text] [Related]
26. Nicotine increases ethanol preference but decreases locomotor activity during the initial stages of chronic ethanol withdrawal.
Lallemand F; Ward RJ; De Witte P
Alcohol Alcohol; 2007; 42(3):207-18. PubMed ID: 17526630
[TBL] [Abstract][Full Text] [Related]
27. Bupropion (Zyban, Wellbutrin) inhibits nicotine-induced viral reactivation in herpes simplex virus type 1 latent rabbits.
Myles ME; Azcuy AM; Nguyen NT; Reisch ER; Barker SA; Thompson HW; Hill JM
J Pharmacol Exp Ther; 2004 Nov; 311(2):640-4. PubMed ID: 15254144
[TBL] [Abstract][Full Text] [Related]
28. Bupropion dose-dependently reverses nicotine withdrawal deficits in contextual fear conditioning.
Portugal GS; Gould TJ
Pharmacol Biochem Behav; 2007 Dec; 88(2):179-87. PubMed ID: 17868796
[TBL] [Abstract][Full Text] [Related]
29. Effect of nicotine lozenges on affective smoking withdrawal symptoms: secondary analysis of a randomized, double-blind, placebo-controlled clinical trial.
Shiffman S
Clin Ther; 2008 Aug; 30(8):1461-75. PubMed ID: 18803988
[TBL] [Abstract][Full Text] [Related]
30. Rodent models of nicotine withdrawal syndrome.
Malin DH; Goyarzu P
Handb Exp Pharmacol; 2009; (192):401-34. PubMed ID: 19184657
[TBL] [Abstract][Full Text] [Related]
31. Nicotine exposure in adolescence alters the response of serotonin systems to nicotine administered subsequently in adulthood.
Slotkin TA; Seidler FJ
Dev Neurosci; 2009; 31(1-2):58-70. PubMed ID: 19372687
[TBL] [Abstract][Full Text] [Related]
32. Effects of nicotine on sleep during consumption, withdrawal and replacement therapy.
Jaehne A; Loessl B; Bárkai Z; Riemann D; Hornyak M
Sleep Med Rev; 2009 Oct; 13(5):363-77. PubMed ID: 19345124
[TBL] [Abstract][Full Text] [Related]
33. Reversal of triazolam tolerance and withdrawal-induced hyperlocomotor activity and anxiety by bupropion in mice.
Joshi D; Naidu PS; Singh A; Kulkarni SK
Pharmacology; 2005 Oct; 75(2):93-7. PubMed ID: 16088250
[TBL] [Abstract][Full Text] [Related]
34. Chronic nicotine doses down-regulate PDE4 isoforms that are targets of antidepressants in adolescent female rats.
Polesskaya OO; Smith RF; Fryxell KJ
Biol Psychiatry; 2007 Jan; 61(1):56-64. PubMed ID: 16814262
[TBL] [Abstract][Full Text] [Related]
35. Bupropion and its main metabolite reverse nicotine chronic tolerance in the mouse.
Grabus SD; Carroll FI; Damaj MI
Nicotine Tob Res; 2012 Nov; 14(11):1356-61. PubMed ID: 22589419
[TBL] [Abstract][Full Text] [Related]
36. Association between 5-hydroxytryptamine transporter gene-linked polymorphic region and smoking behavior in Chinese males.
Chu SL; Xiao D; Wang C; Jing H
Chin Med J (Engl); 2009 Jun; 122(12):1365-8. PubMed ID: 19567154
[TBL] [Abstract][Full Text] [Related]
37. Behavioural and pharmacological mechanisms of bupropion's anti-smoking effects: recent preclinical and clinical insights.
Paterson NE
Eur J Pharmacol; 2009 Jan; 603(1-3):1-11. PubMed ID: 19101536
[TBL] [Abstract][Full Text] [Related]
38. Association of different susceptibilities to morphine with the expression of 5-HTT and 5-HT1AR mRNA in brain regions of SD rats.
Chen HX; Wang Y; Ye MJ; Zhang RL; Li CQ; Hao W
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2008 Sep; 33(9):775-83. PubMed ID: 18812655
[TBL] [Abstract][Full Text] [Related]
39. Effect of nicotine treatment and withdrawal on random-pattern skin flaps in rats.
Campos JH; Gomes HC; dos-Santos WL; Cardeal M; Ferreira LM
Exp Toxicol Pathol; 2008 Sep; 60(6):449-52. PubMed ID: 18691857
[TBL] [Abstract][Full Text] [Related]
40. Clozapine inhibits development and expression of nicotine-induced locomotor sensitization in rats.
Kayir H; Goktalay G; Yildirim M; Uzbay TI
Synapse; 2009 Jan; 63(1):15-21. PubMed ID: 18925656
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
